Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: A suggested therapeutic approach

Nephron

Volumn 87, Issue 4, 2001, Pages 361-364

  Trimarchi, Hernán ^a   Freixas, E ^a   Rabinovich, O ^a   Schropp, J ^a   Pereyra, H ^a   Bullorsky, E ^a  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

Author keywords

Cyclosporine; D dimer; Daclizumab; Fibrinogen degradation products; FK 506; Kidney transplantation; Panel reactive antibodies; Plasma infusions; Plasmapheresis; Thrombotic microangiopathy

Indexed keywords

CYCLOSPORIN; FIBRINOGEN DEGRADATION PRODUCT; INTERLEUKIN 2 RECEPTOR ANTIBODY; TACROLIMUS;

ADULT; ALLOGRAFT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; GRAFT VERSUS HOST REACTION; HEMOLYSIS; HUMAN; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; PLASMAPHERESIS; PRIORITY JOURNAL; RECEPTOR AFFINITY; RISK BENEFIT ANALYSIS; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; BLOOD COMPONENT TRANSFUSION; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOLYSIS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MICROCIRCULATION; MIDDLE AGED; PLASMAPHERESIS; POLYCYSTIC KIDNEY DISEASES; TACROLIMUS; THROMBOSIS;

EID: 0035095151     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045943     Document Type: Article

References (12)

1. Cyclosporine nephropathy
2. Cyclosporine-associated thrombotic microangiopathy in renal allografts
3. Successful renal transplantation after cyclosporine-associated hemolytic-uremic syndrome following bilateral lung transplantation
4. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients. Advantage of FK-506 therapy?
5. Microvascular changes in renal allografts associated with FK-506 (tacrolimus) therapy
6. Microangiopathic hemolytic anemia complicating FK-506 (tacrolimus) therapy
7. Thrombotic microangiopathy in renal transplant recipients treated with cyclosporin A
8. Shared cadaver donor-husband HLA class I mismatches as a risk factor for renal graft rejection in previously pregnant women
9. FK-506-associated thrombotic microangiopathy. Report of two cases and review of the literature
10. The pathogenesis and treatment of hemolytic uremic syndrome
11. A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation
12. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome